Change in shelf-life, storage conditions and manufacturing site for Tegretol 200 Tablet 200mg (SIN00352P)

Novartis would like to inform healthcare professionals of the change in the shelf life, storage conditions and manufacturing site for Tegretol 200 tablet 200mg. Due to these changes, healthcare professionals are advised not to mix the Tegretol tablets from the two different manufacturing sites when dispensing the medication. Healthcare professionals should inform patients of the changes and to advise them to complete the consumption of their old Tegretol tablets, manufactured by “Novartis Pharmaceuticals UK Ltd”, before starting on the new Tegretol tablets manufactured by “Novartis Farma SPA”. Please refer to the Dear Healthcare Professional Letter for more details.
Healthcare professional, Therapeutic Products
Published:

Dear Healthcare Professional Letters

12 Dec 2019

Only abstracts of the Dear Healthcare Professional Letters (DHCPL) are provided on this website. Details of the letters can be found on the MOH Alert System, which is accessible via the Health Professionals Portal (HPP). HPP is a one-stop portal for all healthcare professionals in Singapore. Dentists, medical doctors and pharmacists may access HPP at https://www.hpp.moh.gov.sg/, and follow the procedures below to access the MOH Alert system.

Step 1: Scroll down to the bottom navigation panel of the HPP web page. Under the Healthcare Professionals section, expand the dropdown option for ‘Healthcare Professional Portal’ and select your profession. You will be redirected to the specific HPP web page to log in.

Step 2: Click on the Restricted Content icon on the left panel of the web page and log in via SingPass.

Step 3: Click on the MOH Alert icon under the ‘Applications’ section.

Step 4: Click on the Drug Alert tab to view the DHCPLs.